The gold complexes’ ability to selectively block AQP3 activity highlights a potential therapeutic strategy in targeting cancer progression through the modulation of oxidative stress.[51] The overlap in targeting redox‐sensitive pathways between enzyme inhibition and transmembrane protein modification illustrates how Au(III) complexes can be strategically tailored to different cellular contexts, making them adaptable tools in therapeutic development. This evidence concerns the gene AQP3 and cancer.